Hangjia Medical Holdings Limited (Hangjia Medical) submitted the next-day disclosure report on September 12, 2024, disclosing changes in the company's shares. The report shows that Hangjia Medical repurchased shares through the provisions of the Hong Kong Stock Exchange (HKEX) from September 2 to September 12, 2024, and intends to cancel the repurchased shares. The total number of repurchased shares is 4,597,400 shares, accounting for 0.728% of the issued shares. The highest repurchase price was HKD 18.2396, and the lowest repurchase price was HKD 15.0835. The company confirms that all repurchase activities have been formally authorized and approved by the board of directors and comply with all applicable listing rules, laws, and other regulatory requirements. In addition, within 30 days after the repurchase of shares, that is, until October 12, 2024, Hangjia Medical will not issue any new shares or resell or transfer treasury shares.

Hangjia Medical Holdings Limited (Hangjia Medical) submitted the next-day disclosure report on September 12, 2024, disclosing changes in the company's shares. The report shows that Hangjia Medical repurchased shares through the provisions of the Hong Kong Stock Exchange (HKEX) from September 2 to September 12, 2024, and intends to cancel the repurchased shares. The total number of repurchased shares is 4,597,400 shares, accounting for 0.728% of the issued shares. The highest repurchase price was HKD 18.2396, and the lowest repurchase price was HKD 15.0835. The company confirms that all repurchase activities have been formally authorized and approved by the board of directors and comply with all applicable listing rules, laws, and other regulatory requirements. In addition, within 30 days after the repurchase of shares, that is, until October 12, 2024, Hangjia Medical will not issue any new shares or resell or transfer treasury shares.